NM_000531.6:c.482A>G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000531.6(OTC):c.482A>G(p.Asn161Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N161D) has been classified as Pathogenic.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTC | NM_000531.6 | c.482A>G | p.Asn161Ser | missense_variant | Exon 5 of 10 | ENST00000039007.5 | NP_000522.3 | |
| OTC | NM_001407092.1 | c.482A>G | p.Asn161Ser | missense_variant | Exon 7 of 12 | NP_001394021.1 | ||
| OTC | XM_017029556.2 | c.482A>G | p.Asn161Ser | missense_variant | Exon 5 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:3
This variant, NM_000531.5(OTC):c.482A>G (p.Asn161Ser), is classified as pathogenic based on multiple lines of evidence. It is a nonsynonymous substitution in exon 5 of the OTC gene, which is associated with X-linked ornithine transcarbamylase deficiency, a urea cycle disorder. The variant is absent from major population databases including gnomAD, ESP, and 1000 Genomes, supporting PM2. In silico tools predict a damaging effect on the protein: PolyPhen-2 scores it as probably damaging (0.998), MutationTaster predicts it as deleterious (score = 1), and REVEL assigns a high score of 0.87. The affected residue is highly conserved (GERP score: 5.97), and the change occurs at a site where other pathogenic variants have been reported, fulfilling PM5. Functional studies cited in the literature (PMID: 17041896) demonstrate a deleterious impact on enzyme function, supporting PS3. Furthermore, the variant is reported as pathogenic in ClinVar,and was not detected in either parent, indicating a likely de novo event (PS2 or PM6 if confirmed). Based on ACMG/AMP guidelines, the variant meets criteria PM2, PS3, PM5, PM3, PP3, PP5, and PP2, supporting its classification as pathogenic. -
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 161 of the OTC protein (p.Asn161Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with ornithine transcarbamylase deficiency (PMID: 8786061, 11388595, 12083811, 21956151, 25994866). ClinVar contains an entry for this variant (Variation ID: 97216). Experimental studies have shown that this missense change affects OTC function (PMID: 17041896). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
- -
Published functional studies demonstrate a damaging effect: expression studies demonstrate no residual OTC enzyme activity compared to wildtype (Kim et al., 2006); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 7627182, 21956151, 11388595, 19138872, 12754713, 25994866, 17334707, 12083811, 11117428, 30223008, 28324312, 32034732, 33272297, 32778825, 37146589, 32447331, 32922350, 27915290, 17041896, 28266016) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at